These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 37020276)
1. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors. Parvin S; Akter J; Takenobu H; Katai Y; Satoh S; Okada R; Haruta M; Mukae K; Wada T; Ohira M; Ando K; Kamijo T BMC Cancer; 2023 Apr; 23(1):313. PubMed ID: 37020276 [TBL] [Abstract][Full Text] [Related]
2. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Jacquemont C; Taniguchi T Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210 [TBL] [Abstract][Full Text] [Related]
3. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor. Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438 [TBL] [Abstract][Full Text] [Related]
5. Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition. Sanmartín E; Muñoz L; Piqueras M; Sirerol JA; Berlanga P; Cañete A; Castel V; Font de Mora J Clin Cancer Res; 2017 Nov; 23(22):6875-6887. PubMed ID: 28830922 [No Abstract] [Full Text] [Related]
6. Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines. Kubota E; Williamson CT; Ye R; Elegbede A; Peterson L; Lees-Miller SP; Bebb DG Cell Cycle; 2014; 13(13):2129-37. PubMed ID: 24841718 [TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism. Mandriota SJ; Valentijn LJ; Lesne L; Betts DR; Marino D; Boudal-Khoshbeen M; London WB; Rougemont AL; Attiyeh EF; Maris JM; Hogarty MD; Koster J; Molenaar JJ; Versteeg R; Ansari M; Gumy-Pause F Oncotarget; 2015 Jul; 6(21):18558-76. PubMed ID: 26053094 [TBL] [Abstract][Full Text] [Related]
8. ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms. Southgate HED; Chen L; Tweddle DA; Curtin NJ Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32354033 [No Abstract] [Full Text] [Related]
9. ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition. Gilardini Montani MS; Prodosmo A; Stagni V; Merli D; Monteonofrio L; Gatti V; Gentileschi MP; Barilà D; Soddu S J Exp Clin Cancer Res; 2013 Nov; 32(1):95. PubMed ID: 24252502 [TBL] [Abstract][Full Text] [Related]
10. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Weston VJ; Oldreive CE; Skowronska A; Oscier DG; Pratt G; Dyer MJ; Smith G; Powell JE; Rudzki Z; Kearns P; Moss PA; Taylor AM; Stankovic T Blood; 2010 Nov; 116(22):4578-87. PubMed ID: 20739657 [TBL] [Abstract][Full Text] [Related]
11. Detection of impaired homologous recombination repair in NSCLC cells and tissues. Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959 [TBL] [Abstract][Full Text] [Related]
12. Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway. Jang SW; Jung JK; Kim JM Cell Cycle; 2016 Sep; 15(17):2336-45. PubMed ID: 27398742 [TBL] [Abstract][Full Text] [Related]
13. EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity. Pfäffle HN; Wang M; Gheorghiu L; Ferraiolo N; Greninger P; Borgmann K; Settleman J; Benes CH; Sequist LV; Zou L; Willers H Cancer Res; 2013 Oct; 73(20):6254-63. PubMed ID: 23966292 [TBL] [Abstract][Full Text] [Related]
14. Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks. Shen C; Oswald D; Phelps D; Cam H; Pelloski CE; Pang Q; Houghton PJ Cancer Res; 2013 Jun; 73(11):3393-401. PubMed ID: 23633493 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma. George SL; Lorenzi F; King D; Hartlieb S; Campbell J; Pemberton H; Toprak UH; Barker K; Tall J; da Costa BM; van den Boogaard ML; Dolman MEM; Molenaar JJ; Bryant HE; Westermann F; Lord CJ; Chesler L EBioMedicine; 2020 Sep; 59():102971. PubMed ID: 32846370 [TBL] [Abstract][Full Text] [Related]
16. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518 [TBL] [Abstract][Full Text] [Related]
17. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication. Spriggs CC; Laimins LA mBio; 2017 Feb; 8(1):. PubMed ID: 28196964 [TBL] [Abstract][Full Text] [Related]
18. Expression of DNA repair proteins in endometrial cancer predicts disease outcome. Mhawech-Fauceglia P; Wang D; Kim G; Sharifian M; Chen X; Liu Q; Lin YG; Liu S; Pejovic T Gynecol Oncol; 2014 Mar; 132(3):593-8. PubMed ID: 24508840 [TBL] [Abstract][Full Text] [Related]
19. Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma. Beumer JH; Fu KY; Anyang BN; Siegfried JM; Bakkenist CJ BMC Cancer; 2015 Oct; 15():649. PubMed ID: 26438152 [TBL] [Abstract][Full Text] [Related]
20. ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib. Wang C; Jette N; Moussienko D; Bebb DG; Lees-Miller SP Transl Oncol; 2017 Apr; 10(2):190-196. PubMed ID: 28182994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]